Risk Factors for Hepatitis C

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
A podcast from Mayo Clinic Medical Edge discusses risk factors for contracting hepatitis C. Before 1992, when effective screening tools were developed, blood transfusions and blood products posed the greatest risk of transmitting hepatitis C. Today, injecting drugs is the top risk factor, and anything that can lead to the exposure of other peoples’ blood is a risk as well. Hugging, kissing, and sharing silverware, however, pose no risk of transmission. Nonetheless, given that treatments for hepatitis C are not 100% effective, prevention is extremely important.
 
To listen to the podcast, click here.
Related Articles
The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.
The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.
A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.
Gilead Sciences Inc. has reported positive results from its phase 2 and phase 3 studies on ledipasvir 90 mg/sofosbuvir 400 mg in patients with chronic hepatitis C virus.
Latest Issues
$auto_registration$